Insider transactions

Pedro P Granadillo

CIK 1217544 · Board of Director · last filed 2025-07-18

"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.

Loading insider history…
Disclosed Exposure
$1.83M
Companies
8
Total Filings
66
Lifetime Open-Market Net
-$7.89M

Charts

Trading activity, where the exposure sits, and each trade against the stock price.

HAE price and trades

Daily close with each Form 4 filing on this company marked: green = open-market buy, red = open-market sale, purple = grants, exercises, gifts and other non-market transactions. Marker size scales with the dollar value.

Shares held

Shares owned after each reported transaction on this company (direct holdings as reported).

Open-market buying and selling

by month

Dollar value of open-market purchases (code P, up) and sales (code S, down) across all companies, by filing month. Grants, exercises and gifts are excluded.

Exposure by company

latest
OfficerDirector10% owner* stale (no filing in 3 yrs)

Most recently reported shares × current price. Faded bars (*) have had no filing in 3 years, so the person may no longer hold them. Click a bar to chart that company.

Holdings By Company

Latest on-record share count from this person's most recent non-derivative Form 4 transaction in each company. Disclosed exposure = shares × current underlying price.
Symbol Role Shares Price Disclosed Exposure Lifetime OM Net Filings Latest Filed
ROCKET PHARMACEUTICALS, INC. (RCKTW) Delisted Director 30,000 $0.00 $60 $0 3 2025-07-18
RCKT Director — $2.28 — $0 5 2022-06-15
HAE Director 15,335 $119.19 $1.83M -$7.98M 22 2018-11-09
NPS PHARMACEUTICALS INC (NPSP) Delisted Director 0 — — $0 14 2015-02-24
CAPRICOR THERAPEUTICS, INC. (NLTXW) Delisted Director 27,588 — — $0 2 2011-05-12
NOVEN PHARMACEUTICALS INC (NOVN) Delisted Director 0 $0.09 $0 $99.6K 7 2009-08-27
CAPRICOR THERAPEUTICS, INC. (NLTX) Delisted Director 28 $13.96 $391 $0 2 2009-07-23
FIRST INDIANA CORP (FINB) Delisted Director 0 — — $0 2 2008-01-02

Recent Filings · Page 2 of 7

66 filings
Insider activity across all companies, newest first. Form 4 rows are post-trade confirmations (buys, sells, grants, exercises). Notice (144) rows are pre-trade notices of intent to sell restricted or control stock under Rule 144 — they may not all execute. Compare adjacent dates to see which notices became actual sales.
Filed Symbol Action Net Shares Net $ Link
2018-04-02 RCKT Grant (A) — $0 EDGAR
2017-12-04 HAE Mixed — -$161.3K EDGAR
2017-07-31 HAE Grant (A) +4,329 $170.0K EDGAR
2015-07-23 HAE Grant (A) +4,337 $0 EDGAR
2015-02-24 NPS PHARMACEUTICALS INC (NPSP) Delisted Mixed −30,413 -$1.40M EDGAR
2015-02-20 NPS PHARMACEUTICALS INC (NPSP) Delisted Grant (A) — $0 EDGAR
2015-02-19 HAE Mixed — -$161.0K EDGAR
2014-07-25 HAE Grant (A) +2,394 $0 EDGAR
2014-07-08 HAE Mixed — -$104.3K EDGAR
2014-03-12 HAE Mixed — -$108.6K EDGAR
Showing 11–20 of 66
Page 2 of 7
Form 4 codes: P = open-market purchase · S = open-market sale · A = grant/award · M = option exercise · F = tax withholding at vest · G = bona-fide gift · D = disposition to issuer · J = other (see filing footnote). Only P / S codes carry directional signal.
Notice (144 / 144/A): Form 144 is a notice of intent to sell restricted/control stock under Rule 144, filed before the sale; 144/A is an amendment. Many notices are pre-scheduled under Rule 10b5-1 plans. A Form 4 with code S typically follows within a few days when the planned sale executes; missing follow-up Form 4s suggest the notice was cancelled or modified.